Tizanidne Hydrochloride Capsule
Product Images NDC 67877-612

7 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 67877-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

Tiz01 (Tiz01)
Chemical structure diagram of Tizanidine hydrochloride, showing its molecular components and bonds including a chloro-substituted benzene ring fused with a thiazole and an imidazoline moiety.*
FDA Label Image

Tiz02 (Tiz02)

Tiz02 (Tiz02)
A line graph showing plasma Tizanidine concentration (ng/mL) over time (hours) from dosing. The chart compares 2 x 4 mg and 2 x 2 mg Tizanidine tablets and capsules, with and without food, depicting their concentration profiles up to 24 hours post-dose.*
FDA Label Image

Tiz03 (Tiz03)

Tiz03 (Tiz03)
Line graph depicting improvement in Ashworth Score over 6 hours post-dose. It compares three groups receiving placebo, 8 mg tizanidine, and 16 mg tizanidine, showing greater improvement with higher tizanidine doses and a peak effect around 2 hours post-dose.*
FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)
A line plot with error bars showing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Two groups are compared: tizanidine (mean dose 28.8 mg) with scores improving (negative values) and placebo with scores near zero or slightly positive. The y-axis measures improvement in Ashworth Score, ranging from -6 to 2.*
FDA Label Image

Tiz05new-a (Tiz05new A)

Tiz05new-a (Tiz05new A)
Label for Tizanidine Capsules 2 mg, oral capsules supplied in a package of 150 capsules. The label includes storage instructions, dosage information, manufacturer details (Alkem Laboratories Ltd., Mumbai, India), distributor (Ascend Laboratories, LLC, Bedminster, NJ), and a barcode. The product is marked Rx Only and features the Ascend Laboratories logo.*
FDA Label Image

Tiz08new-a (Tiz08new A)

Tiz08new-a (Tiz08new A)
Label for Tizanidine Capsules 4 mg oral capsules from Ascend Laboratories, LLC. The label includes dosage strength, NDC 67877-611-15, a capsule count of 150, storage instructions, manufacturer details (Alkem Laboratories Ltd., India), and distributor information (Ascend Laboratories, NJ). It also displays a barcode and instructions for child-resistant packaging.*
FDA Label Image

Tiz11new-a (Tiz11new A)

Tiz11new-a (Tiz11new A)
Label for Tizanidine Capsules 6 mg oral capsules by Ascend Laboratories, LLC. The label indicates a package size of 150 capsules with Rx only status. It includes storage instructions, manufacturer and distributor information, barcode, and NDC 67877-612-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.